Onconova Therapeutics (NASDAQ:ONTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Onconova Therapeutics missed estimated earnings by 5.26%, reporting an EPS of $-0.2 versus an estimate of $-0.19.
Revenue was down $0.00 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 5.38% drop in the share price the next day.
Here's a look at Onconova Therapeutics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.27 | -0.33 | -0.28 | -0.45 |
| EPS Actual | -0.16 | -0.22 | -0.27 | -0.30 |
| Revenue Estimate | 60.00K | 50.00K | 20.00K | 60.00K |
| Revenue Actual | 56.00K | 57.00K | 57.00K | 56.00K |
To track all earnings releases for Onconova Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
